• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MUSCULOSKELETAL TRANSPLANT FOUNDATION DBX PUTTY, 10CC; FILLER, BONE VOID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MUSCULOSKELETAL TRANSPLANT FOUNDATION DBX PUTTY, 10CC; FILLER, BONE VOID Back to Search Results
Model Number 038100
Device Problem Contamination (1120)
Patient Problem Hepatitis (1897)
Event Date 06/21/2016
Event Type  Injury  
Manufacturer Narrative
Implanted.
 
Event Description
On 1/27/2017, mtf was notified that a patient of dr.(b)(6) who was implanted with dbx three weeks ago tested (b)(6).
 
Manufacturer Narrative
All assigned investigation tasks have been completed.There were no patient safety concerns or trends identified; no core gtp violations were noted.The donor and processing batch records for donor (b)(6) were re-reviewed.The donor was appropriately screened and tested in accordance with mtf's donor release criteria.The subject allograft met specification and was appropriately released for distribution and transplantation.The complaint unit was not returned to mtf for evaluation as the graft was implanted.There have been no additional complaints or adverse events received for donor (b)(6).A total of (b)(4) dbx putty units were produced from this donor, all of which have been distributed.There are 25 tissue trace records on file; there is a record on file is for the complaint unit.Environmental data showed that the locations were in control.As per mtf's medical director (dr.(b)(6)), "report of pos (b)(6) test in patient who received dbx implant weeks before.Attempts to get further info on this patient about how long they were known to be pos or what signs and symptoms were present or what risk behaviors were known were unsuccessful.In addition, (b)(6) is widely prevalent to otherwise well patients undergoing surgery.And dbx is highly processed by techniques validated to inactivate viruses including (b)(6).Thus there is no evidence to link the graft to the patient's test result." the investigation is considered closed.
 
Event Description
On 1/27/2017, mtf was notified that a patient of dr.(b)(6) who was implanted with dbx three weeks ago tested (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DBX PUTTY, 10CC
Type of Device
FILLER, BONE VOID
Manufacturer (Section D)
MUSCULOSKELETAL TRANSPLANT FOUNDATION
125 may street
edison NJ 08837
Manufacturer (Section G)
MUSCULOSKELETAL TRANSPLANT FOUNDATION
125 may street
edison NJ 08837
Manufacturer Contact
mary agostisi
125 may street
edison, NJ 08837
7326613160
MDR Report Key6365389
MDR Text Key68550494
Report Number2249062-2017-00001
Device Sequence Number1
Product Code MBP
Combination Product (y/n)N
PMA/PMN Number
K040262
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date01/21/2018
Device Model Number038100
Device Catalogue Number038100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/27/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
-
-